RANTES-induced T cell activation correlates with CD3 expression

Area of Science:

• Immunology
• Cell Signaling

Background:

• Chemokines like RANTES are crucial for immune cell communication.
• T cell activation involves complex signaling pathways, including G-protein and tyrosine kinase cascades.
• RANTES exhibits unique signaling properties in T cells, distinct from other chemokines.

Purpose of the Study:

• To investigate the unique biphasic signaling of RANTES in T cells.
• To elucidate the role of T cell receptor (TCR) and CD3 expression in RANTES-mediated signaling.
• To understand the mechanism behind RANTES' distinct T cell activation pathway.

Main Methods:

• Utilized Jurkat T cell lines with varying CD3 expression levels.
• Stimulated cells with RANTES and anti-CD3 monoclonal antibody (mAb).
• Analyzed cytoplasmic Ca2+ signals and correlated responses with CD3 and TCR expression.

Main Results:

• Identified a RANTES-induced second phase of calcium signaling, dependent on tyrosine kinase activity and high RANTES concentrations (>100 nM).
• Demonstrated that only CD3(high) Jurkat T cells responded to RANTES via this pathway.
• Showed that RANTES-induced activation requires the T cell receptor (TCR), even with low-level RANTES-specific chemokine receptor expression.

Conclusions:

• RANTES induces a unique biphasic calcium signal in T cells, with the second phase mimicking T cell receptor activation.
• TCR signaling is essential for RANTES-mediated T cell activation, particularly in CD3(high) cells.
• This TCR-dependent pathway contributes to RANTES' distinct signaling profile in T cells.